Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | T5D73 | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y004114 | SC / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 3RE73 | IM / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y014181 | SC / LA |
Patient began experiencing an adverse reaction the day following vaccination (04/22/2025). She presented to our clinic an additional day following (04/23/2025). Patient had a swollen, red area about 4 inches in length and 2 inches in width at the site of the varicella vaccine (back of left arm). The area was red with small, raised bumps. Patient stated that the area was painful and pulsating. She stated that she experienced a fever the day following the vaccine but was unable to report her exact temperature. She also experienced fatigue, headache, and tightness in her chest. Patient has a history of asthma, but did not feel the need to use her inhaler. At the time she presented to our clinic (04/23/2025 at 4:10pm) she was still experiencing tightness in her chest, fatigue, and pain, but stated that symptoms were starting to feel better. Patient had not had the varicella vaccine before but stated she had the chickenpox as a child. At that time her vitals were as follows: Temperature 97.5F, Blood Pressure 112/81, Pulse 79 bpm, O2 sat on right arm 99%. Patient was instructed to go to urgent care and was given a note explaining what has been stated above, which vaccines she received and where they were given, and vital signs at 4:10pm that she could take to urgent care.
asthma
aspirin, morphine